Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform
I Wessel, L H Jensen, P B Jensen, J Falck, A Rose, M Roerth, J L Nitiss, M Sehested
52Citationer
(Scopus)
Fingeraftryk
Dyk ned i forskningsemnerne om 'Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform'. Sammen danner de et unikt fingeraftryk.